Apollo Endosurgery Inc. (APEN) Business Metric Overview - Stocknear

Apollo Endosurgery Inc.

NASDAQ: APEN · Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM

Apollo Endosurgery Revenue Breakdown

Period Ending Jun 30, 2018 Mar 31, 2018 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Other Products Revenue 300K 243K 207K 202K 163K
Other Products Revenue Growth +23.46% +17.39% +2.48% +23.93% n/a
Surgical Revenue 4.72M 5.2M 7.03M 7.42M 7.13M
Surgical Revenue Growth -9.22% -25.94% -5.23% +4.07% n/a

Revenue by Geography

Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Non-Us Revenue 2K 4K 4K 3K 5K 14K 1K 13K 31K 2.93M 1.21M 17.18M 42K 18.05M 23.55M 22.48M 20.51M 23.5M 8.46M 39.2M 8.64M 8.08M 6.77M
Non-Us Revenue Growth -50.00% 0.00% +33.33% -40.00% -64.29% +1300.00% -92.31% -58.06% -98.94% +142.79% -92.98% +40807.14% -99.77% -23.36% +4.75% +9.62% -12.76% +177.69% -78.41% +353.60% +6.98% +19.36% n/a
United States Revenue 161K 191K 186K 197K 205K 215K 232K 242K 599K 4.73M 2.38M 14.61M 183K 14.85M 17.16M 14.76M 17.06M 18.84M 7.28M 23.93M 7.9M 9.06M 7.86M
United States Revenue Growth -15.71% +2.69% -5.58% -3.90% -4.65% -7.33% -4.13% -59.60% -87.35% +98.57% -83.69% +7885.25% -98.77% -13.42% +16.20% -13.45% -9.44% +158.77% -69.58% +202.78% -12.76% +15.33% n/a

Operating Expense Breakdown

Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 15.2M 13.78M 14.17M 13.45M 11.86M 10.7M 11.34M 8.86M 7.77M 6.55M 4.42M 9.67M 10.1M 9.65M 11.15M 11.41M 11.6M 10.37M 11.74M 12.56M 11.51M 10.84M 11.86M 12.57M 18.08M 1.52M 1.73M 963.51K 935.72K 858.01K 1.1M 1.05M
Selling, General, and Administrative Revenue Growth +10.29% -2.76% +5.33% +13.41% +10.87% -5.70% +28.04% +13.96% +18.65% +48.17% -54.27% -4.31% +4.66% -13.39% -2.35% -1.60% +11.92% -11.70% -6.57% +9.19% +6.19% -8.60% -5.66% -30.48% +1087.67% -12.25% +80.03% +2.97% +9.06% -22.12% +4.85% n/a
Research and Development Revenue 3.48M 2.8M 2.92M 2.71M 2.48M 2.57M 2.55M 1.93M 2.19M 1.52M 1.81M 2.15M 2.14M 2.13M 2.69M 3.43M 2.9M 3.67M 3.15M 2.46M 1.88M 2.18M 2.29M 1.96M 5.34M 538.08K 935.62K 991.91K 1.41M 1.43M 2.92M 2.76M
Research and Development Revenue Growth +24.05% -3.94% +7.52% +9.44% -3.43% +0.67% +32.26% -11.80% +43.63% -16.14% -15.46% +0.37% +0.52% -20.86% -21.56% +18.41% -21.14% +16.39% +28.42% +30.71% -13.73% -4.68% +16.76% -63.35% +892.30% -42.49% -5.67% -29.74% -1.28% -50.97% +5.85% n/a
Sales and Marketing Revenue 10.08M 8.58M 9.13M 8.22M 7.39M 6.12M 6M 4.79M 4.58M 4.18M 2.27M 6.33M 6.74M 6.5M 7.8M 7.7M 7.75M 7.34M 8.49M 9.24M 8.08M 7.98M 8.61M 8.38M 8.05M n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth +17.38% -5.97% +11.06% +11.19% +20.74% +1.97% +25.37% +4.54% +9.67% +84.46% -64.22% -6.01% +3.70% -16.76% +1.38% -0.72% +5.57% -13.49% -8.18% +14.45% +1.25% -7.31% +2.72% +4.04% n/a n/a n/a n/a n/a n/a n/a n/a